COMP <GO>
UHS vs ENSG // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Universal Health Services Inc. (NYSE) VS. The Ensign Group Inc. (NASDAQ) • 15-METRIC TALLY: UHS 8
— ENSG 5
■ METRIC PARITY
LAST: $176.05 (-0.32%) • MKT CAP: $10.38B
options-implied-move
—
LAST: $181.52 (-2.58%) • MKT CAP: $10.59B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UHS VS. ENSG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UHS | ENSG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 20.10% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.10% | 18.00% | -3.90 | ENSG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.0x | 17.0x | -12.00 | UHS | /valuation <GO> |
| Free Cash Flow Yield | 8.16% | 3.11% | +5.05 | UHS | /fcf-yield <GO> |
| Operating Margin | 11.50% | 8.50% | +3.00 | UHS | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 6.80% | +1.80 | UHS | /net-margins <GO> |
| Revenue Growth (YoY) | 9.70% | 18.80% | -9.10 | ENSG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.49% | 0.13% | +0.36 | UHS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.11 | 3.73 | -0.62 | ENSG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | UHS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.7 | 54.1 | -8.40 | ENSG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.89 | +0.15 | UHS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.5x | 26.5x | -20.00 | UHS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.38B | $10.59B | -$214.2M | ENSG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UHS REV | ENSG REV | UHS GROSS % | ENSG GROSS % | UHS FCF | ENSG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.36B | $5.03B | — | 20.1% | $849.2M | $337.8M |
| FY 2024 | $15.83B | $4.24B | — | 20.3% | $1.12B | $156.5M |
| FY 2023 | $14.28B | $3.71B | — | — | $625.1M | $209.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UHS // BETA 1.04
ENSG // BETA 0.89